Interactions between viral and human genes

被引：7

作者：

Griffiths, PD

机构：

来源：

REVIEWS IN MEDICAL VIROLOGY | 2002年 / 12卷 / 04期

关键词：

D O I：

10.1002/rmv.364

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：197 / 199

页数：3

共 23 条

[1] PROTECTION AFFORDED BY SICKLE-CELL TRAIT AGAINST SUBTERTIAN MALARIAL INFECTION [J].

ALLISON, AC .

BRITISH MEDICAL JOURNAL, 1954, 1 (4857) :290-294

[2] The CCR5Δ32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment [J].

Barroga, CF ;

Raskino, C ;

Fangon, MC ;

Palumbo, PE ;

Baker, CJ ;

Englund, JA ;

Spector, SA .

JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (02) :413-419

[3] RESISTANCE TO PARVOVIRUS B19 INFECTION DUE TO LACK OF VIRUS RECEPTOR (ERYTHROCYTE P-ANTIGEN) [J].

BROWN, KE ;

HIBBS, JR ;

GALLINELLA, G ;

ANDERSON, SM ;

LEHMAN, ED ;

MCCARTHY, P ;

YOUNG, NS .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (17) :1192-1196

[4] Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene [J].

Coffey, AJ ;

Brooksbank, RA ;

Brandau, O ;

Oohashi, T ;

Howell, GR ;

Bye, JM ;

Cahn, AP ;

Durham, J ;

Heath, P ;

Wray, P ;

Pavitt, R ;

Wilkinson, J ;

Leversha, M ;

Huckle, E ;

Shaw-Smith, CJ ;

Dunham, A ;

Rhodes, S ;

Schuster, V ;

Porta, G ;

Yin, L ;

Serafini, P ;

Sylla, B ;

Zollo, M ;

Franco, B ;

Bolino, A ;

Seri, M ;

Lanyi, A ;

Davis, JR ;

Webster, D ;

Harris, A ;

Lenoir, G ;

St Basile, GD ;

Jones, A ;

Behloradsky, BH ;

Achatz, H ;

Murken, J ;

Fassler, R ;

Sumegi, J ;

Romeo, G ;

Vaudin, M ;

Ross, MT ;

Meindl, A ;

Bentley, DR .

NATURE GENETICS, 1998, 20 (02) :129-135

[5] CC chemokine receptor 5 and renal-transplant survival [J].

Fischereder, M ;

Luckow, B ;

Hocher, B ;

Wüthrich, RP ;

Rothenpieler, U ;

Schneeberger, H ;

Panzer, U ;

Stahl, RAK ;

Hauser, IA ;

Budde, K ;

Neumayer, HH ;

Krämer, BK ;

Land, W ;

Schlöndorff, D .

LANCET, 2001, 357 (9270) :1758-1761

[6]

Griffiths PD, 2000, REV MED VIROL, V10, P351, DOI 10.1002/1099-1654(200011/12)10:6<351::AID-RMV302>3.0.CO

[7]

2-Y

[8] Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism [J].

Helminen, ME ;

Kilpinen, S ;

Virta, M ;

Hurme, M .

JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (06) :777-780

[9] CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: Association with increased 2-year maternal mortality [J].

John, GC ;

Bird, T ;

Overbaugh, J ;

Nduati, R ;

Mbori-Ngacha, D ;

Rostron, T ;

Dong, T ;

Kostrikis, L ;

Richardson, B ;

Rowland-Jones, SL .

JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (01) :89-92

[10] Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines [J].

Kaslow, RA ;

Rivers, C ;

Tang, JM ;

Bender, TJ ;

Goepfert, PA ;

El Habib, R ;

Weinhold, K ;

Mulligan, MJ .

JOURNAL OF VIROLOGY, 2001, 75 (18) :8681-8689

← 1 2 3 →